Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other neoplasm 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 26Lymphoma, Follicular 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, Lymphocytic, Chronic, B-Cell 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Non-Hodgkin 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, Mantle-Cell 23Lymphoma, Large-Cell, Immunoblastic 23Leukemia, Myeloid, Acute 22Burkitt Lymphoma 22Hodgkin Disease 21Lymphoma 20Congenital Abnormalities 19Sezary Syndrome 18Mycosis Fungoides 18Multiple Myeloma 18Leukemia, Myeloid, Chronic-Phase 18Leukemia, Myeloid, Accelerated Phase 18Blast Crisis 17Leukemia 16Neoplasms, Plasma Cell 15Myelodysplastic Syndromes 15Waldenstrom Macroglobulinemia 14Lymphoma, Large-Cell, Anaplastic 14Lymphoma, Extranodal NK-T-Cell 14Leukemia, Myelomonocytic, Chronic 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Myeloproliferative Disorders 13Dendritic Cell Sarcoma, Interdigitating 13

Interventions

Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3liposomal amphotericin B 2fludarabine phosphate 2Morphine 2Methylprednisolone 2Filgrastim 2Fentanyl 2Cyclosporine 2Caspofungin 2Antilymphocyte Serum 2pyroxamide 1ferrous sulfate 1ferric gluconate 1Whole-Body Irradiation 1Watchful Waiting 1Therapeutics 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sucrose 1Radiotherapy 1Prednisone 1Phenytoin 1Pemetrexed 1Oxycodone 1Ondansetron 1Mycophenolic Acid 1Music Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Busulfan × Dermatologic × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡